ECG detection of murine chagasic cardiomyopathy

Journal of Parasitology

Volumn 96, Issue 4, 2010, Pages 758-764

  Eickhoff, Christopher S ^a   Lawrence, Cade T ^a   Sagartz, John E ^a   Bryant, Leesa A ^a   Labovitz, Arthur J ^a   Gala, Simil S ^a   Hoft, Daniel F ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; HISTOPATHOLOGY; PARASITE INFESTATION; PARASITIC DISEASE; PROTOZOAN; RODENT; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAZIL; CARDIOMYOPATHY; CHAGAS DISEASE; ELECTROCARDIOGRAM; FEMALE; HISTOPATHOLOGY; IMMUNOPATHOLOGY; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; QT INTERVAL; QT PROLONGATION; SCREENING TEST; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS CARDIOMYOPATHY; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; FEMALE; INFLAMMATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, SCID; MUSCLE, SKELETAL; MYOCARDIUM; STATISTICS, NONPARAMETRIC;

MURINAE; MUS; TRYPANOSOMA CRUZI;

EID: 77956156780     PISSN: 00223395     EISSN: 19372345     Source Type: Journal    
DOI: 10.1645/GE-2396.1     Document Type: Article

References (21)

1. ANDRADE, A. L., C. M. MARTELLI, R. M. OLIVEIRA, S. A. SILVA, A. I. AIRES, L. M. SOUSSUMI, D. T. COVAS, L. S. SILVA, J. G. ANDRADE, L. R. TRAVASSOS, and I. C. ALMEIDA. 2004. Short report: Benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up. American Journal of Tropical Medicine and Hygiene 71: 594-597.
2. BRAGA, M. S., L. LAURIA-PIRES, E. R. ARGANARAZ, R. J. NASCIMENTO, AND A. R. TEIXEIRA. 2000. Persistent infections in chronic Chagas' diseasepatients treated with anti-Trypanosoma cruzi nitroderivatives. Revista do Instituto de Medicina Tropical de Sao Paulo 42: 157-161.
3. BUSTAMANTE, J. M., H. W. RIVAROLA, A. R. FERNANDEZ, J. E. ENDERS, R. FRETES, J. A. PALMA, AND P. A. PAGLINI-OLIVA. 2002. Trypanosoma cruzi reinfections in mice determine the severity of cardiac damage. International Journal for Parasitology 32: 889-896.
4. CANCADO, J. R. 2002. Long term evaluation of etiological treatment of Chagas' disease with benznidazole. Revista do Instituto de Medicina Tropical de Sao Paulo 44: 29-37.
5. CASTRO, J. A., M. M. DE MECCA, AND L. C. BARTEL. 2006. Toxic side effects of drugs used to treat Chagas' disease (American trypanoso-miasis). Human and Experimental Toxicology 25: 471-479
6. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). 2007. Blood donor screening for Chagas' disease-United States, 2006-2007. Morbidity and Mortality Weekly Report 56: 141-143.
7. DUmONTEIL, E., J. ESCOBEDO-ORTEGON, N. REYES-RODRIGUEZ, A. ARJONA-TORRES, AND M. J. RAMIREZ-SIERRA. 2004. Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice. Infection and Immunity 72: 46-53.
8. GARCIA, S., C. O. RAMOS, J. F. SENRA, F. VILAS-BOAS, M. M RODRIGUES, A. C. CAMPOS-DE-CARVALHO, R. RIBEIRO-DOS-SANTOS, and M. B. SOARES. 2005. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations. Antimicrobial Agents and Chemotherapy 49: 1521-1528.
9. GARG, N., AND R. L. TARLETON. 2002. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infection and Immunity 70: 5547-5555.
10. GIDDINGS, O. K., C. S. EICKHOFF, T. J. SMITH, L. A. BRYANT, AND D. F. HOFT. 2006. Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection. Infection and Immunity 74: 5549-5560.
11. HOFT, D. F. 1996. Differential mucosal infectivity of different life stages of Trypanosoma cruzi. American Journal of Tropical Medicine and Hygiene 55: 360-364.
12. -, AND C. S. EICKHOFF. 2002. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infection and Immunity 70: 6715-6725.
13. + CTL and B cell-mediated cross-priming. Journal of Immunology 179: 6889-6900.
14. LAURIA-PIRES, L., M. S. BRAGA, A. C. VEXENAT, N. NITZ, A. SIMOES-BARBOSA, D. L. TINOCO, AND A. R. TEIXEIRA. 2000. Progressive chronic Chagas' heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives. American Journal of Tropical Medicine and Hygiene 63: 111-118.
15. MARINHO, C. R., D. Z. BUCCI, M. L. DAGLI, K. R. BASTOS, M. G. GRISOTTO, L. R. SARDINHA, C. R. BAPTISTA, C. P. GONCALVES, M. R. LIMA, and J. M. ALVAREZ. 2004. Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: A model for genetic studies of Chagas' disease. Infection and Immunity 72: 2350-2357.
16. POSTAN, M., J. J. BAILEY, J. A. DVORAK, J. P. MCDANIEL, AND E. W. POTTALA. 1987. Studies of Trypanosoma cruzi clones in inbred mice III. Histopathological and electrocardiographical responses to chronic infection. American Journal of Tropical Medicine and Hygiene 37: 541-549.
17. -, A. W. CHEEVER, J. A. DVORAK, AND J. P. MCDANIEL. 1986. A histopathological analysis of the course of myocarditis in C3H/He mice infected with Trypanosoma cruzi clone Sylvio-X10/4. Transactions of the Royal Society of Tropical Medicine and Hygiene 80: 50-55.
18. SALLES, G., S. XAVIER, A. SOUSA, A. HASSLOCHER-MORENO, AND C. CARDOSO. 2003. Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: Results of a long-term follow-up study. Circulation 108: 305-312.
19. SCHNAPP, A. R., C. S. EICKHOFF, D. SIZEMORE, R. CURTISS III, AND D. F. HOFT. 2002. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infection and Immunity 70: 5065-5074.
20. VIOTTI, R., C. VIGLIANO, B. LOCOCO, G. BERTOCCHI, M. PETTI, M. G. ALVAREZ, M. POSTAN, AND A. ARMENTI. 2006. Long-term cardiac outcomes of treating chronic Chagas' disease with benznidazole versus no treatment: A nonrandomized trial. Annals of Internal Medicine 144: 724-734.
21. WILLIAMS-BLANGERO, S., T. MAGALHAES, E. RAINWATER, J. BLANGERO, R. CORREA-OLIVEIRA, AND J. L. VANDEBERG. 2007. Electrocardiographic characteristics in a population with high rates of seropositivity for Trypanosoma cruzi infection. American Journal of Tropical Medicine and Hygiene 77: 495-499.